Innophos Holdings

Innophos Holdings Inc., a Cranbury, N.J.-based specialty phosphates company, has set its proposed IPO terms to around 8.7 million common shares being offered art between $14 and $16 per share. It plans to trade on the Nasdaq under ticker symbol IPHS, with Bear Stearns and Credit Suisse serving as co-lead underwriters. Bain Capital acquired Innophos in 2004 from Rhodia for $550 million.